Vox Markets Logo

Morgan Advanced Materials lays out growth plans

11:31, 24th April 2024
Vox News
Company News
TwitterFacebookLinkedIn

Morgan Advanced Materials (MGAM) Follow | MGAM updated the market on its financial goals on Wednesday, as it aimed to surpass organic revenue growth rates through a combination of organic expansion, strategic mergers and acquisitions, and shareholder value creation.
The FTSE 250 company, which was holding its capital markets day, said in terms of organic revenue growth, it was aiming towards the upper end of its 4% to 7% per annum guidance range over the next four years through strategic investments.

It added that it was looking to achieve an attractive adjusted operating profit margin ranging between 12.5% and 15%, with a clear path towards the higher end of that spectrum.

The company was also aiming to sustain a robust return on invested capital (ROIC) in the range of 17% to 20%.

Additionally, Morgan Advanced Materials said it intended to maintain a prudent leverage range between 1.0x and 1.5x, or up to 2.0x adjusted EBITDA post-acquisition.

That approach would leverage the company's solid balance sheet to fund organic growth initiatives and strategic acquisitions.

At 1137 BST, shares in Morgan Advanced Materials were up 1.51% at 303p.

Reporting by Josh White for Sharecast.com.

Stock Chart | MGAM
TwitterFacebookLinkedIn

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Recent Articles
  • London close: Stocks rise as US payrolls come in weaker

    21 hours ago

    London markets closed positively on Friday, as investors digested slower-than-expected payrolls growth in the US, while Anglo American jumped amid anticipation of a potential bidding war for the mining giant.

  • FTSE 250 movers: Trainline rolling; Georgia banks out of favour

    21 hours ago

    FTSE 250 (MCX) 20,198.09 0.73%

  • FTSE 100 movers: Anglo rallies on Reuters report; IHG slumps

    21 hours ago

    London's FTSE 100 was up 0.5% at 8,209.34 in afternoon trade on Friday.

  • Berenberg raises target price on Standard Chartered

    23 hours ago

    Analysts at Berenberg raised their target price on multinational bank Standard Chartered from 1,050.0p to 1,100.0p on Friday after the group's Q1 earnings "validated" management's suggestion that the bank had experienced "an encouraging start" to the year.

  • Citi sees significant upside at Team17

    23 hours ago

    Citi has reiterated its 'buy' rating for British video-game developer Team17, saying it sees significant upside to its valuation as operations stabilise.

  • Jefferies downgrades AJ Bell after share price rally

    23 hours ago

    Jefferies downgraded its stance on AJ Bell on Friday to 'hold' from 'buy' after a circa 30% rally in the shares this year.

  • Triple Point to sell part of portfolio after shareholder consultation

    23 hours ago

    Triple Point Social Housing announced plans to sell part of its portfolio on Friday, following shareholder consultations.

  • Adriatic Metals announces resignation of CFO

    23 hours ago

    Adriatic Metals, the FTSE 250 precious and base metals miner, has announced that its chief financial officer is stepping down after just two years on the job.

  • CMA set for deeper probe of Pennon's SES acquisition

    23 hours ago

    Pennon Group worked to assure the market that its acquisition of Sutton and East Surrey Water (SES Water) would avoid a deeper competition probe on Friday, telling shareholders that it planned to offer "appropriate undertakings" to regulators.

  • Angle strikes supplier deal with AstraZeneca

    23 hours ago

    Liquid biopsy technology firm Angle has struck a supplier deal with pharmaceutical giant AstraZeneca to develop an androgen receptor detection assay to enhance prostate cancer studies.

Watchlist